Lori Anderson of XIFIN to share views on the current state of informatics in precision medicine as well as challenges and future trends for this field…
Managing and Maximizing the Volumes of Data Coming from Genomic Analysis Read More »
Michael Astion, MD, PhD, to share how the philosophy of the “two rights” can drive alignment and compromise among payers, providers, and patients…
How to Get Payers and Providers on the Same Page with Genetic Testing Reimbursement Read More »
Mayo Clinic professor Richard Weinshilboum, MD, describes a near future in which preemptive gene sequencing becomes standard of care for safe and effective drug therapies…
Pharmacogenomics to Eventually Touch Every Patient, Everywhere, Expert Says Read More »
It’s been a little more than a year since Geisinger launched its National Precision Health Initiative, a first-of-its kind unit designed to advance the promise of anticipatory medicine at Geisinger and at healthcare systems throughout the United States…
Geisinger Health Seeks to Help Eliminate ‘Sick Care’ Nationally Read More »
Rapidly falling costs and the increasing clinical value of human genome sequencing and genetic testing is reaching the point where innovative hospitals and health networks are ready to offer these services to patients in family practice settings…
Prominent health networks/hospitals participate in NIH genetic research supported by more than one billion dollars in funding from the federal government…
Ongoing growth in consumer genetic testing pressures hospitals and healthcare networks to educate and prepare their primary care physicians for informed patients…
Syapse of San Francisco has created a precision medicine council that quickly attracted 200 of the biggest hospitals and health networks as members…
Hospitals and healthcare systems increasingly using genomic profiling must integrate it into all facets of care delivery, not just add it to patients’ EHRs…
When a health network CEO considers how to introduce a precision medicine service into clinical care, the up-front costs can be substantial, but the potential rewards are significant …
